Startup AI Diagnostics showcased its tuberculosis monitor at MWC 2026, which could one day scan for other lung- and heart-related diseases.
HOUSTON, Feb. 16, 2026 /PRNewswire/ -- New data presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) from the NRG/NSABP B-42 trial demonstrated that the Endocrine Activity Index (EAI) ...
Delphi Diagnostics' Endocrine Activity Index® (EAI™) test can provide actionable information for prognosis and prediction of dose-intense taxane-based chemotherapy benefit in stage II-III, HR+ HER2- ...
REDMOND, WA, UNITED STATES, January 15, 2026 /EINPresswire.com/ — The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic ...
The final, formatted version of the article will be published soon. Background: The kappa free light chain (k-FLC) index is a sensitive marker of intrathecal immunoglobulin (Ig) synthesis and is ...
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ — Daisy Genomics Inc. (“Daisy Genomics”) and New Day Diagnostics (“New Day”) have announced ...
Please provide your email address to receive an email when new articles are posted on . A novel AI multimodal model outperformed Oncotype DX in overall distant recurrence rate at 15 years. Additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results